Product Overview
Dragon Pharma Minoxidil is an oral tablet line, supplied as 10 mg tablets in packs of 100, so the tablet can be divided when a lower amount is wanted. The compound is a prodrug: the body converts it into minoxidil sulfate through the enzyme SULT1A1, and that active form opens ATP-sensitive potassium channels in vascular smooth muscle, which relaxes the vessel wall and lowers pressure. Nothing in that mechanism targets hair directly, and that is exactly why the drug has a second life.
Hair growth appeared in the clinical work as an unwanted effect: patients treated for high blood pressure grew more hair, including on the face and body. The finding turned a vasodilator into a hair-loss treatment, at first as a topical solution and later as low oral amounts used off-label. The oral route is systemic, so it reaches every follicle that responds to the signal rather than only the area where a solution is rubbed in. That reach is the advantage and the source of the body-hair complaint at the same time.
The pharmacokinetics are worth knowing before anything else on this page. Oral minoxidil has an elimination half-life of about three to four hours, with a mean of roughly four hours in the review literature consulted here, while the topical format sits near twenty-two hours. The blood pressure effect outlives the plasma curve by a long way and can persist for up to about seventy-two hours. On our pack the 10 mg strength corresponds to the high-dose section of the hypertension protocols, so it is the format that is split rather than swallowed whole. Two items that pair with it in this brand section are Finasteride 5 mg for the hormonal side of hair loss and GHK-CU 10 mg on the cosmetic peptide shelf; when the driver is a cycle rather than genetics, the question usually starts with the Testosterone line, where Enantat 250 and Deca 300 are the two names that come up most often in hair-related threads.
Dosage Protocol
Two different dose worlds share one tablet: the low amounts used off-label for hair and the higher amounts that belong to hypertension treatment. The table separates them and keeps the escalation step explicit, because blood pressure is what limits the higher end.
| Low dose for hair | 1.25-2.5 mg a day is the off-label range in the project reference data; a 10 mg tablet is divided to reach it |
| Antihypertensive start | About 5 mg a day is the usual start in hypertension protocols, with titration upwards under pressure control |
| High dose | 10 mg a day and above belongs to hypertension protocols and needs monitoring; this tablet matches that section |
| Female | 1.25-2.5 mg a day appears as the low-dose hair protocol for women; no separate female athletic dosing is confirmed in the sources |
| Administration | Oral, once a day; divided tablets only, and blood pressure has to be checked because the vasodilator effect is strong |
| Time to judge | Months, not weeks: the first assessment of hair response is made no earlier than three to six months |
Suggested Protocols
Every card below links to a product page and all of them sit inside the Dragon Pharma section. These are reference groupings drawn from how the compound is described in the source material, not validated treatment plans.
What to Expect
- A shedding phase first. Weeks one and two usually bring a temporary loss of telogen hairs. It is a recognised part of starting the drug and not a reason to stop.
- Pressure and fluid, early. Between weeks two and four the vasodilator effect shows up as lower readings and possible oedema when amounts in the antihypertensive range are used.
- First visible hair. Around months three to six the response becomes visible. The best results are described in younger men whose hair loss started less than five years earlier.
- Main density result. Months six to twelve is when the effect on density is judged, which is also why a dermatology review is timed around the six-month mark.
- Body and face hair. Hypertrichosis is a known effect of the oral route and is reported more often in women. It follows the same mechanism as the scalp response.
- Stopping resets the picture. Hair benefits fade over months after the drug is stopped and pressure returns to its earlier level once the compound has cleared.
- Scale of the effect. This is not a treatment that creates new follicles; it extends the growth phase of follicles that are still active, so the ceiling depends on how much hair is left.
Side Effects and Management
The cardiovascular effects come first in the source material, because they are the ones tied to the amount used and to the reason the drug exists as a prescription product.
Discontinuation and Monitoring
No hormonal recovery step belongs to this drug. Minoxidil does not suppress the gonadal axis, so it is not a compound that needs a SERM after it, and the schedule that matters is a monitoring schedule instead.
